These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 9446010)
1. [Inflammation and bone metabolism in rheumatoid arthritis. Pathogenetic viewpoints and therapeutic possibilities]. Oelzner P; Hein G Med Klin (Munich); 1997 Oct; 92(10):607-14. PubMed ID: 9446010 [TBL] [Abstract][Full Text] [Related]
2. Mediators of inflammation and bone remodeling in rheumatic disease. Shaw AT; Gravallese EM Semin Cell Dev Biol; 2016 Jan; 49():2-10. PubMed ID: 26481971 [TBL] [Abstract][Full Text] [Related]
3. [Rheumatism and bone metabolism]. Dischereit G; Lange U Orthopade; 2019 Nov; 48(11):911-916. PubMed ID: 31531702 [TBL] [Abstract][Full Text] [Related]
4. Osteoclasts, pro-inflammatory cytokines, RANK-L and bone remodeling in rheumatoid arthritis. Kaplan C; Finnegan A Front Biosci; 2003 May; 8():d1018-29. PubMed ID: 12700082 [TBL] [Abstract][Full Text] [Related]
5. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Edwards CJ; Williams E Osteoporos Int; 2010 Aug; 21(8):1287-93. PubMed ID: 20229200 [TBL] [Abstract][Full Text] [Related]
6. Alfacalcidol versus plain vitamin D in inflammation induced bone loss. Scharla SH; Schacht E; Lempert UG J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of bone loss: rheumatoid arthritis, periodontal disease and osteoporosis. Hayward M; Fiedler-Nagy C Agents Actions; 1987 Dec; 22(3-4):251-4. PubMed ID: 3328495 [No Abstract] [Full Text] [Related]
8. [Pathophysiology of bone loss in rheumatic diseases--do bone markers help in monitoring?]. Hein GE Z Rheumatol; 2001 Apr; 60(2):113-5. PubMed ID: 11383046 [No Abstract] [Full Text] [Related]
9. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy]. Schacht E Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429 [TBL] [Abstract][Full Text] [Related]
10. CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts. Pathak JL; Bakker AD; Verschueren P; Lems WF; Luyten FP; Klein-Nulend J; Bravenboer N PLoS One; 2015; 10(6):e0131041. PubMed ID: 26103626 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Goldring SR; Gravallese EM Arthritis Res; 2000; 2(1):33-7. PubMed ID: 11094416 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. Manolagas SC; Jilka RL N Engl J Med; 1995 Feb; 332(5):305-11. PubMed ID: 7816067 [TBL] [Abstract][Full Text] [Related]
13. [Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches]. Ringe JD Z Rheumatol; 1996; 55(3):149-57. PubMed ID: 8768144 [TBL] [Abstract][Full Text] [Related]
14. Osteoblasts and osteoclasts in bone remodeling and inflammation. Tanaka Y; Nakayamada S; Okada Y Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):325-8. PubMed ID: 16101541 [TBL] [Abstract][Full Text] [Related]